Oct 1 (Reuters) – AbbVie Inc.: * ABBVIE – PHASE 3 STUDIES SHOW CONTINUED REPIGMENTATION WITH RINVOQ THROUGH WEEK 76 * ABBVIE – RINVOQ PLUS NB-UVB SHOWS HIGHER REPIGMENTATION THAN RINVOQ ALONE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 1 (Reuters) - Italy posted a state sector budget deficit of €27 billion ($30.29…
VIDEO SHOWS: GIANT BILLBOARD READING (English): ‘WELCOME TO SHAMCHESTER’ / ARCHIVE STILL PHOTOS OF THE…
Oct 1 (Reuters) - Florida Attorney General James Uthmeier on Thursday filed a lawsuit against…
Sept 30 (Reuters) - Constellation Energy and Amazon.com on Wednesday announced a 20-year power purchase…
WASHINGTON, Oct 1 (Reuters) - New York's attorney general on Thursday led a coalition of…
VIDEO SHOWS: ATP 500 JAPAN OPEN FIRST ROUND HIGHLIGHTS COMPLETE SHOTLIST TO FOLLOW SHOWS: TOKYO,…